ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,259, issued on May 26, was assigned to Sumitomo Pharma Co. Ltd. (Osaka, Japan). "Transdermal absorption preparation" was invented by Eri Ich... Read More
ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,260, issued on May 26, was assigned to CHENGDU XINRUI TAIKANG TECHNOLOGY Co. LTD. (Chengdu, China). "Application of Alpha-asarone in prepara... Read More
ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,261, issued on May 26. "Treatment of inflammation initiated by the spinal cord injury, the traumatic brain injury, stroke, in inhibition of ... Read More
ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,262, issued on May 26, was assigned to Neuheit Pharma Technologies Pvt. Ltd. (Hyderabad, India). "Process for the preparation of topical for... Read More
ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,263, issued on May 26, was assigned to Zhejiang Medicine Co. LTD Xinchang Pharmaceutical Factory (Xinchang, China). "Carotenoid compound com... Read More
ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,264, issued on May 26, was assigned to Genemo Inc. (San Diego). "Methods and materials for diagnosis and treatment of neuronal disorder" was... Read More
ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,265, issued on May 26, was assigned to Bexson Biomedical Inc. (Santa Barbara, Calif.). "Compositions of complexing agents" was invented by J... Read More
ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,266, issued on May 26, was assigned to Rivo Bio Inc. (Boston). "Indane-, indene-, azaindane-, and azaindene-amines as activators of serotoni... Read More
ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,267, issued on May 26, was assigned to DAEWOONG THERAPEUTICS INC. (Suwon-si, South Korea) and DAEWOONG PHARMACEUTICAL Co. LTD. (Hwaseong-si, ... Read More
ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,268, issued on May 26, was assigned to Dompe' Farmaceutici SPA (Milan). "CXCL8 inhibitors for use in the treatment of COVID-19" was invented... Read More